Masayuki Sonoda

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Chemotherapy in the outpatient setting is effective in improving patients' quality of life (QOL). However, the increasing availability of targeted molecular agents in addition to conventional anti-cancer medications has placed increased importance on managing adverse events and educating patients about side effects that can affect their QOL. We developed an(More)
  • 1